Microneedle-assisted dual delivery of PUMA gene and celastrol for synergistic therapy of rheumatoid arthritis through restoring synovial homeostasis

Abnormal proliferation of aggressive fibroblast-like synoviocytes (FLS) and perpetuate synovial inflammation can inevitably accelerate the progression of rheumatoid arthritis (RA). Herein, a strategy of simultaneously promoting FLS apoptosis and inhibiting inflammation as mediated by macrophages is...

Full description

Bibliographic Details
Main Authors: Peng Hua, Ruifeng Liang, Suleixin Yang, Yanbei Tu, Meiwan Chen
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2024-06-01
Series:Bioactive Materials
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2452199X24000756
_version_ 1797287559176388608
author Peng Hua
Ruifeng Liang
Suleixin Yang
Yanbei Tu
Meiwan Chen
author_facet Peng Hua
Ruifeng Liang
Suleixin Yang
Yanbei Tu
Meiwan Chen
author_sort Peng Hua
collection DOAJ
description Abnormal proliferation of aggressive fibroblast-like synoviocytes (FLS) and perpetuate synovial inflammation can inevitably accelerate the progression of rheumatoid arthritis (RA). Herein, a strategy of simultaneously promoting FLS apoptosis and inhibiting inflammation as mediated by macrophages is proposed to restore synovial homeostasis for effective RA therapy. A hyaluronic acid-based dissolvable microneedle (MN) is fabricated for transdermal delivery of dual human serum albumin (HSA)-contained biomimetic nanocomplexes to regulate RA FLS and macrophages. Upon skin insertion, dual nanocomplexes are released rapidly from the MN and accumulate in RA joint microenvironment through both passive and active targeting as mediated by HSA. Thioketal-crosslinked fluorinated polyethyleneimine 1.8 K (TKPF) was constructed to bind the plasmid encoding pro-apoptotic gene PUMA with HSA coating layer (TKPF/pPUMA@HSA, TPH). TPH nanocomplexes can upregulate PUMA through RA FLS transfection to trigger efficient apoptosis. Also, HSA nanocomplexes encapsulating the classic anti-inflammatory natural product celastrol (Cel@HSA, CH) can inhibit inflammation of macrophages through blocking NF-κB pathway activation. TPH/CH MN can deplete RA FLS and inhibit M1 macrophage activation, suppress synovial hyperplasia as well as reduce bone and cartilage erosion in a collagen-induced arthritis (CIA) mouse model, demonstrating a promising strategy for efficient RA treatment.
first_indexed 2024-03-07T18:36:06Z
format Article
id doaj.art-4a66ba84ac64424cb7dfcb80de756935
institution Directory Open Access Journal
issn 2452-199X
language English
last_indexed 2024-03-07T18:36:06Z
publishDate 2024-06-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Bioactive Materials
spelling doaj.art-4a66ba84ac64424cb7dfcb80de7569352024-03-02T04:54:36ZengKeAi Communications Co., Ltd.Bioactive Materials2452-199X2024-06-01368395Microneedle-assisted dual delivery of PUMA gene and celastrol for synergistic therapy of rheumatoid arthritis through restoring synovial homeostasisPeng Hua0Ruifeng Liang1Suleixin Yang2Yanbei Tu3Meiwan Chen4State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR, ChinaState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR, ChinaState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR, ChinaState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR, ChinaCorresponding author.; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR, ChinaAbnormal proliferation of aggressive fibroblast-like synoviocytes (FLS) and perpetuate synovial inflammation can inevitably accelerate the progression of rheumatoid arthritis (RA). Herein, a strategy of simultaneously promoting FLS apoptosis and inhibiting inflammation as mediated by macrophages is proposed to restore synovial homeostasis for effective RA therapy. A hyaluronic acid-based dissolvable microneedle (MN) is fabricated for transdermal delivery of dual human serum albumin (HSA)-contained biomimetic nanocomplexes to regulate RA FLS and macrophages. Upon skin insertion, dual nanocomplexes are released rapidly from the MN and accumulate in RA joint microenvironment through both passive and active targeting as mediated by HSA. Thioketal-crosslinked fluorinated polyethyleneimine 1.8 K (TKPF) was constructed to bind the plasmid encoding pro-apoptotic gene PUMA with HSA coating layer (TKPF/pPUMA@HSA, TPH). TPH nanocomplexes can upregulate PUMA through RA FLS transfection to trigger efficient apoptosis. Also, HSA nanocomplexes encapsulating the classic anti-inflammatory natural product celastrol (Cel@HSA, CH) can inhibit inflammation of macrophages through blocking NF-κB pathway activation. TPH/CH MN can deplete RA FLS and inhibit M1 macrophage activation, suppress synovial hyperplasia as well as reduce bone and cartilage erosion in a collagen-induced arthritis (CIA) mouse model, demonstrating a promising strategy for efficient RA treatment.http://www.sciencedirect.com/science/article/pii/S2452199X24000756Rheumatoid arthritisPUMACelastrolAnti-inflammationFibroblast-like synoviocyte apoptosis
spellingShingle Peng Hua
Ruifeng Liang
Suleixin Yang
Yanbei Tu
Meiwan Chen
Microneedle-assisted dual delivery of PUMA gene and celastrol for synergistic therapy of rheumatoid arthritis through restoring synovial homeostasis
Bioactive Materials
Rheumatoid arthritis
PUMA
Celastrol
Anti-inflammation
Fibroblast-like synoviocyte apoptosis
title Microneedle-assisted dual delivery of PUMA gene and celastrol for synergistic therapy of rheumatoid arthritis through restoring synovial homeostasis
title_full Microneedle-assisted dual delivery of PUMA gene and celastrol for synergistic therapy of rheumatoid arthritis through restoring synovial homeostasis
title_fullStr Microneedle-assisted dual delivery of PUMA gene and celastrol for synergistic therapy of rheumatoid arthritis through restoring synovial homeostasis
title_full_unstemmed Microneedle-assisted dual delivery of PUMA gene and celastrol for synergistic therapy of rheumatoid arthritis through restoring synovial homeostasis
title_short Microneedle-assisted dual delivery of PUMA gene and celastrol for synergistic therapy of rheumatoid arthritis through restoring synovial homeostasis
title_sort microneedle assisted dual delivery of puma gene and celastrol for synergistic therapy of rheumatoid arthritis through restoring synovial homeostasis
topic Rheumatoid arthritis
PUMA
Celastrol
Anti-inflammation
Fibroblast-like synoviocyte apoptosis
url http://www.sciencedirect.com/science/article/pii/S2452199X24000756
work_keys_str_mv AT penghua microneedleassisteddualdeliveryofpumageneandcelastrolforsynergistictherapyofrheumatoidarthritisthroughrestoringsynovialhomeostasis
AT ruifengliang microneedleassisteddualdeliveryofpumageneandcelastrolforsynergistictherapyofrheumatoidarthritisthroughrestoringsynovialhomeostasis
AT suleixinyang microneedleassisteddualdeliveryofpumageneandcelastrolforsynergistictherapyofrheumatoidarthritisthroughrestoringsynovialhomeostasis
AT yanbeitu microneedleassisteddualdeliveryofpumageneandcelastrolforsynergistictherapyofrheumatoidarthritisthroughrestoringsynovialhomeostasis
AT meiwanchen microneedleassisteddualdeliveryofpumageneandcelastrolforsynergistictherapyofrheumatoidarthritisthroughrestoringsynovialhomeostasis